The prevalence of hepatitis C virus infection in Egypt 2015: implications for future policy on prevention and treatment.
about
National treatment programme of hepatitis C in Egypt: Hepatitis C virus model of care.Assessment of the Relation Between SNP in MxA Gene and the Responsiveness of Egyptian HCV Genotype 4 Patients to Pegylated Interferon and Ribavirin TreatmentHepatitis C infection in Egypt: prevalence, impact and management strategies.Real life Egyptian experience of efficacy and safety of Simeprevir/Sofosbuvir therapy in 6211 chronic HCV genotype IV infected patients.Curbing the hepatitis C virus epidemic in Pakistan: the impact of scaling up treatment and prevention for achieving elimination.Characterizing hepatitis C virus epidemiology in Egypt: systematic reviews, meta-analyses, and meta-regressions.Expression Analysis of Liver-Specific Circulating microRNAs in HCV-Induced Hepatocellular Carcinoma in Egyptian Patients.Assessment of auditory functions in chronic hepatitis C patients treated by sofosbuvir.Sofosbuvir–daclatasvir improves hepatitis C virus–induced mixed cryoglobulinemia: Upper Egypt experience.Hepatitis C Virus Exposure Rate among Health-care Workers in Rural Lower Egypt GovernoratesChallenge of hepatitis C in Egypt and hepatitis B in MauritaniaTowards hepatitis C virus elimination: Egyptian experience, achievements and limitations
P2860
Q30238676-F61DEE66-682D-402B-B6E3-285436DA63C2Q33625258-337C3DAA-A21E-4466-8A2A-E7BB61A9700BQ33713718-C89F2835-1E64-4C4A-9CC1-C12607F687E5Q38991020-DEB143AE-C37A-4FC3-B005-F66E65DE27BFQ47197986-6A69C1E3-3FC8-432E-9791-37395BF1FAA0Q47548612-FD18D8DD-F5C2-4652-8D38-5B4F2C814858Q47553678-64C2530B-1593-46F8-B0CC-81BA86365864Q55405964-1BB789DB-7280-415C-8930-C3E15AC106ABQ55449137-CE5C4811-ECF6-438C-A1E4-63B29D039E61Q56532291-D9E64BF6-79E4-44FE-ADD4-150D763F1AE2Q57491236-3446AD2B-BB5F-4F78-BA4C-744D4488E2A5Q57815114-FE7C3D11-1CF1-43EF-80EF-691EDCA75976
P2860
The prevalence of hepatitis C virus infection in Egypt 2015: implications for future policy on prevention and treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The prevalence of hepatitis C ...... y on prevention and treatment.
@en
The prevalence of hepatitis C ...... y on prevention and treatment.
@nl
type
label
The prevalence of hepatitis C ...... y on prevention and treatment.
@en
The prevalence of hepatitis C ...... y on prevention and treatment.
@nl
prefLabel
The prevalence of hepatitis C ...... y on prevention and treatment.
@en
The prevalence of hepatitis C ...... y on prevention and treatment.
@nl
P2093
P2860
P356
P1433
P1476
The prevalence of hepatitis C ...... y on prevention and treatment.
@en
P2093
Amr Kandeel
Anna L Funk
Maha Talaat
Mohamad Genedy
Samir El-Refai
P2860
P356
10.1111/LIV.13186
P577
2016-06-08T00:00:00Z